Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
85.12
+2.40 (2.90%)
Aug 4, 2026, 12:13 PM EDT - Market open

Inhibrx Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-130.19-140.061,688-241.36-145.23-81.77
Depreciation & Amortization
2.352.482.291.191.231.2
Stock-Based Compensation
11.3411.1458.5224.8520.4515.05
Other Adjustments
4.494.25-1,9956.675.092.72
Change in Receivables
0.050.240.36-0.520.62-0.14
Changes in Accounts Payable
-0.13-3.317.92.11-0.71-4.64
Changes in Accrued Expenses
-17.43-4.3635.8826.077.6-3.74
Changes in Unearned Revenue
----0.17-1.98-1.67
Changes in Other Operating Activities
-2.39-0.2-2.09-12.15-2.38-7.33
Operating Cash Flow
-131.93-129.79-194.41-193.31-115.3-80.32
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.03-2.6-4.59-0.69-0.86
Sale of Property, Plant & Equipment
-0---0.06
Investing Cash Flow
-0.01-0.03-2.6-4.59-0.69-0.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
74.9999.97--128.8639.99
Net Long-Term Debt Issued (Repaid)
74.9999.97--128.8639.99
Issuance of Common Stock
0.821.6171.68202.32130.1344.16
Net Common Stock Issued (Repurchased)
0.821.6171.68202.32130.1344.16
Other Financing Activities
--0.13--0.36-0.44-0.38
Financing Cash Flow
77.07101.4571.68201.96258.5583.77

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-26-28.38-125.334.06142.562.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-131.94-129.83-197.01-197.9-115.99-81.19
Free Cash Flow Growth
------
FCF Margin
--9986.54%-98503.00%-10994.60%-5291.38%-1122.76%
Free Cash Flow Per Share
-8.50-8.38-13.15-16.80-2.89-2.14
Levered Free Cash Flow
-72.81-45.51,739-230.53-13.28-58.82
Unlevered Free Cash Flow
-140.67-140.43-280.07-206.76-126.04-93.61
SEC Filings: 10-K · 10-Q